期刊文献+

高尿酸血症与骨质疏松、高血糖、肥胖等在体检人群中的相关性分析 被引量:7

Relationship about Hyperuricemia and Osteoporosis,Plasma Glucose and Obesity in Population of Health Examine
下载PDF
导出
摘要 目的探讨高尿酸血症与骨质疏松、高血糖、血脂、肥胖、年龄、性别等的关系。方法对2036名参加健康体检者高尿酸血症与骨质疏松、血脂、血糖、肥胖等相关数据进行统计分析。结果①骨质疏松、血清高甘油三酯、高总胆固醇、高空腹血糖、高血尿酸检出率分别为12.67%、9.63%、7.81%、5.30%、11.89%;②50岁以上人群骨质疏松、高血脂、高血糖检出率显著高于50岁以下人群(P<0.05);③高尿酸血症组中骨质疏松、肥胖、高腰臀比、IFG、高TC、高TG、高血压病的发生率均比正常尿酸组显著增多(P<0.05)。结论骨质疏松、血脂、血糖、血尿酸总趋势均随年龄增长而增高,高尿酸血症与骨质疏松、高血脂、高血糖、肥胖等有较高的相关性。 Objective To evaluate a possible relationship between hyperuricemia and osteoporosis,hyperlipidemia,obesity,age,gender and so on.Methods The relevant data of UA and osteoporosis,obesity,IFG,BP,TG,TC were calculated and analyzed in 2036 persons who underwent health examination.Results ①The detection rates of osteoporosis,high HTG,HTC,IFG and HUA are 12.67%,9.63%,7.81%,5.30% and 11.89%;②The detection rates of osteoporosis and high IFG,HTG and HTC in the people who were over 50 years were significantly higher than under 50 years(P0.05);③The detection rates of osteoporosis and obesity,high WHR,high IFG,HT,HTG,HTC were significantly higher in high uric acid group than in normal uric acid group(P0.05).Conclusion The general trend of osteoporosis and high IFG,HBP,HTG,HTC,HUA all increased with the age;high uric acid level may be an important factor for development and progress of osteoporosis and high IFG,HBP,HTG,HTC.
作者 杨东辉
出处 《哈尔滨医药》 2012年第1期12-13,共2页 Harbin Medical Journal
关键词 高尿酸血症 骨质疏松 甘油三酯 总胆固醇 血糖 健康查体 Hyperuricemia Osteoporosis Triglyceride Total cholesterol Plasma glucose Health examination
  • 相关文献

参考文献7

二级参考文献28

共引文献3933

同被引文献72

  • 1关宝生,白雪,王艳秋,尹相林,李若男,周宪君,徐辉,杜文彦,邱洪斌.痛风/高尿酸血症患者生活习惯的危险因素[J].中国老年学杂志,2014,34(2):455-457. 被引量:62
  • 2赵兰江,赵冬,刘静,王薇,吴桂贤,秦兰萍,刘军,刘飒,王文化,曾哲淳.血清尿酸水平和甘油三酯关系的人群研究[J].中华内科杂志,2005,44(9):664-667. 被引量:57
  • 3欧小虹,夏雪培,林瑞敏.糖尿病下肢血管病变危险因素分析[J].中国糖尿病杂志,2007,15(4):207-209. 被引量:17
  • 4中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5228
  • 5中国健康促进基金会骨质疏松防治中国白皮书编委会.骨质疏松症中国白皮书.中华健康管理学杂志,2009,3(3):148-156.
  • 6Melamed ML, Muntner P, Michos ED, et al. Serum 25- hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004 [J].Arterioscler Thromb Vasc Biol, 2008,28 ( 6 ) : 1179 -1185.
  • 7Ginter E, Simko V. Vitamin D deficiency, atherosclerosis and cancer [J]. Bratisl Lek Listy, 2009,110(12) :751-756.
  • 8Maksimovi~M, Vlajinac H, Radak D, et al. Relationship between sociodemographic, anthropometric and biochemical characteristics and degree of peripheral arterial disease [ J]. Srp Arh Celok Lek, 2010,138(9-10) :584-589.
  • 9Xiang W, Kong J, Chen S, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin- angiotensin systems [ J]. Am J Physiol Endocrinol Metab, 2005, 288( 1 ) :E125-E132.
  • 10Ohsawa M, Koyama T, Yamamoto K, et al. lalpha, 25- di- hydroxyvitamin D (3) and its potent synthetic analogs downregulatetissue factor and upregulate thrombomodulin expression in mono- cytic cells, counteracting the effects of tumor necrosis factor anoxi- dized LDL[J]. Circulation, 2000,102 (23) :2867-2872.

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部